DE3853100D1 - Gewebs-Plasminogen-Aktivator-Analoge mit modifizierten Wachstumsfaktordomänen. - Google Patents

Gewebs-Plasminogen-Aktivator-Analoge mit modifizierten Wachstumsfaktordomänen.

Info

Publication number
DE3853100D1
DE3853100D1 DE3853100T DE3853100T DE3853100D1 DE 3853100 D1 DE3853100 D1 DE 3853100D1 DE 3853100 T DE3853100 T DE 3853100T DE 3853100 T DE3853100 T DE 3853100T DE 3853100 D1 DE3853100 D1 DE 3853100D1
Authority
DE
Germany
Prior art keywords
analogs
growth factor
plasminogen activator
tissue plasminogen
modified growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3853100T
Other languages
English (en)
Other versions
DE3853100T2 (de
Inventor
Eileen R Mulvihill
Patrick J O'hara
Bjorn A Nexo
Shinji Yoshitake
Yasunori Ikeda
Suguru Suzuki
Akira Hashimoto
Teruaki Yuzuriha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Eisai Co Ltd
Zymogenetics Inc
Original Assignee
Novo Nordisk AS
Eisai Co Ltd
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS, Eisai Co Ltd, Zymogenetics Inc filed Critical Novo Nordisk AS
Publication of DE3853100D1 publication Critical patent/DE3853100D1/de
Application granted granted Critical
Publication of DE3853100T2 publication Critical patent/DE3853100T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Semiconductor Integrated Circuits (AREA)
DE3853100T 1987-06-04 1988-06-03 Gewebs-Plasminogen-Aktivator-Analoge mit modifizierten Wachstumsfaktordomänen. Expired - Fee Related DE3853100T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5806187A 1987-06-04 1987-06-04
US16284788A 1988-03-02 1988-03-02

Publications (2)

Publication Number Publication Date
DE3853100D1 true DE3853100D1 (de) 1995-03-30
DE3853100T2 DE3853100T2 (de) 1995-08-03

Family

ID=26737188

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3853100T Expired - Fee Related DE3853100T2 (de) 1987-06-04 1988-06-03 Gewebs-Plasminogen-Aktivator-Analoge mit modifizierten Wachstumsfaktordomänen.

Country Status (14)

Country Link
US (1) US5403734A (de)
EP (1) EP0293936B1 (de)
JP (1) JPS6485079A (de)
KR (1) KR0135427B1 (de)
AT (1) ATE118815T1 (de)
AU (1) AU625752B2 (de)
CA (1) CA1341446C (de)
DE (1) DE3853100T2 (de)
DK (1) DK302388A (de)
ES (1) ES2069536T3 (de)
FI (1) FI101306B (de)
IE (1) IE67036B1 (de)
NO (1) NO179874C (de)
NZ (1) NZ224914A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756093A (en) * 1985-04-22 1998-05-26 Genentech, Inc. Tissue plasminogen activator variants
US5714372A (en) * 1985-04-22 1998-02-03 Genentech, Inc. Tissue plasminogen activator variants
US5736134A (en) * 1985-04-22 1998-04-07 Genentech, In.C Tissue plasminogen activator variants
DE3851259T2 (de) * 1987-06-04 1994-12-15 Zymogenetics Inc Mutierter t-PA mit Kringle-Ersatz.
GB8815135D0 (en) * 1988-06-24 1988-08-03 British Bio Technology Proteins & nucleic acids
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5258180A (en) * 1988-09-02 1993-11-02 Genetech, Inc. Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment
US5087572A (en) * 1989-12-01 1992-02-11 Genentech, Inc. Dna encoding human plasminogen modified at the cleavage site
US5190756A (en) * 1989-12-01 1993-03-02 Genentech, Inc. Methods and materials for expression of human plasminogen variant
JPH0595786A (ja) * 1991-10-07 1993-04-20 Green Cross Corp:The 変異ヒトプロウロキナーゼ
DE10199044I2 (de) * 1992-06-03 2006-02-09 Genentech Inc Varianten des Gewebeplasminogenaktivators mit verbesserter Therapeutischer wirkung
US6706504B1 (en) 1996-11-12 2004-03-16 The Scripps Research Institute Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
CA2807749C (en) * 2010-08-05 2023-02-28 Council Of Scientific & Industrial Research Protein fusion constructs possessing thrombolytic and anticoagulant properties

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68561A (en) * 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
EP0125254A1 (de) * 1982-10-28 1984-11-21 Beecham Group Plc Enzymderivate und deren verwendung bei der behandlung von trombosen
DK149786A (da) * 1985-04-04 1986-10-04 Beecham Group Plc Proteolytisk enzym
FR2581652B1 (fr) * 1985-04-22 1989-12-22 Genentech Inc Nouveaux mutants de l'activateur tissulaire du plasminogene humain
US4916071A (en) * 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator
JP2527454B2 (ja) * 1986-01-31 1996-08-21 ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド 新しい血栓溶解タンパク質
US5376547A (en) * 1987-01-30 1994-12-27 American Home Products Corporation Des-epidermal growth factor plasminogen activators

Also Published As

Publication number Publication date
KR0135427B1 (ko) 1998-04-23
AU1743088A (en) 1988-12-08
EP0293936A3 (en) 1989-09-20
JPH0448434B2 (de) 1992-08-06
EP0293936A2 (de) 1988-12-07
JPS6485079A (en) 1989-03-30
ES2069536T3 (es) 1995-05-16
FI882627A0 (fi) 1988-06-03
NO882454L (no) 1988-12-05
NO179874C (no) 1997-01-02
CA1341446C (en) 2003-11-18
US5403734A (en) 1995-04-04
NO882454D0 (no) 1988-06-03
DK302388D0 (da) 1988-06-03
FI882627A (fi) 1988-12-05
NZ224914A (en) 1991-02-26
FI101306B1 (fi) 1998-05-29
AU625752B2 (en) 1992-07-16
ATE118815T1 (de) 1995-03-15
IE67036B1 (en) 1996-05-15
IE881680L (en) 1988-12-04
FI101306B (fi) 1998-05-29
DE3853100T2 (de) 1995-08-03
DK302388A (da) 1989-02-03
KR890000521A (ko) 1989-03-15
NO179874B (no) 1996-09-23
EP0293936B1 (de) 1995-02-22

Similar Documents

Publication Publication Date Title
DE3853100D1 (de) Gewebs-Plasminogen-Aktivator-Analoge mit modifizierten Wachstumsfaktordomänen.
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
DK302288D0 (da) Proteiner
DK0389035T3 (da) Farmaceutisk præparat der indeholder en farmaceutisk egnet bærer og forbindelsen med strukturen (7alfa,17alfa)-17-hydroxy-7-methyl-19-nor-17-pregn-5-(10)-en-20-yn-3-on
DK0403458T3 (da) Hidtil ukendte polypeptider og anvendelse deraf
DE59005128D1 (de) t-PA pro STABILISIERUNG.
ZA884012B (en) Tissue plasminogen activator analogs having modified growth factor domains
IT1231255B (it) Peptidi anoressizzanti e ipotensivi.
ES2066733A1 (es) Complejo consistente en un activador del plasminogeno y albumina de suero y procedimiento para prepararlo.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee